Sugar Derivatives TRIZ Cases

Replacing toxic organotin compounds with boron in Suzuki-Miyaura coupling eliminates carcinogenic waste while enabling safe imidazopyridine synthesis.

Marker-assisted selection accelerates breeding time while maintaining genetic diversity in soybean variety A1024319.

Inhibiting Trabid reduces TCF transcription to suppress tumour growth while maintaining cellular adhesion integrity.

A computationally derived vaccine approach uses CRISPR to remove high-frequency viral fragments from a super organism genome.

An ICAM-1 antisense oligonucleotide hybridizes to mRNA to inhibit protein synthesis.

Targeting ionotropic receptors Ir25a and Ir93a reduces vector survival by disrupting hygrosensing mechanisms.

Cationically charged nucleic acid terminators reduce dye terminator artifacts by enabling equivalent incorporation of deoxynucleotides and dideoxynucleotides.

Covalent bonding of hydrophilic UV absorbers prevents leaching and tinting while maintaining high water content.

Microsatellite markers SW2196 and SW225 replace invasive intestinal surgery with non-invasive blood sampling for accurate ETEC resistance identification.

Segmenting variable domains into loop regions preserves structural stability while enabling specific antigen binding.

Chemo-enzymatic synthesis overcomes low yields in complex oligosaccharide production by combining chemical glycosylation with enzymatic steps.

Bind and snap segmentation cleaves large polynucleotides into immobilized oligonucleotides to resolve assembly artifacts from long genomic gaps.

C-glycoside keto-amide derivatives form surfactants via condensation of C-glycoside ketones with lipid acyl hydrazides.

MicroRNA expression analysis predicts aggressive disease progression to enable precise treatment selection and reduce side effects.

Amphipathic steviol monoglycosides form micelles to lower surface tension in aqueous solutions.

Lentiviral vectors deliver Nanog shRNA to suppress colorectal carcinoma growth and metastasis.

Chemical modification of adeno-associated virus capsids reduces immune response and proteasome degradation, enabling targeted gene delivery with lower doses.